Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
AMR Action Fund
Biotech
Lack of policy, investment stifling antibiotics pipeline
A razor-thin pipeline of antibiotics and lack of investment requires urgent market reform, AMR Action Fund's CEO told Fierce Biotech.
Gabrielle Masson
Apr 12, 2022 9:00am
Big Pharma-backed AMR Action Fund picks 1st biotech investments
Apr 4, 2022 10:25am
Big Pharma-backed antibiotic R&D fund lands another $140M
Feb 19, 2021 8:35am